Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLIMEPIRIDE\ROSIGLITAZONE vs GLOFITAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GLIMEPIRIDE\ROSIGLITAZONE vs GLOFITAMAB: Safety Overview

Metric GLIMEPIRIDE\ROSIGLITAZONE GLOFITAMAB
Total FAERS Reports 717 1,116
Deaths Reported 74 315
Death Rate 10.3% 28.2%
Hospitalizations 487 492
Average Patient Age 59.5 yrs 62.5 yrs
% Female Patients 43.0% 53.2%
Manufacturer N/A Genentech, Inc.
Route N/A INTRAVENOUS